Auscann Group Holdings Stock Fundamentals
| ACNNFDelisted Stock | USD 0 0.0007 22.58% |
AusCann Group Holdings fundamentals help investors to digest information that contributes to AusCann Group's financial success or failures. It also enables traders to predict the movement of AusCann Pink Sheet. The fundamental analysis module provides a way to measure AusCann Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AusCann Group pink sheet.
AusCann |
AusCann Group Holdings Company Shares Outstanding Analysis
AusCann Group's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AusCann Group Shares Outstanding | 440.55 M |
Most of AusCann Group's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AusCann Group Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, AusCann Group Holdings has 440.55 M of shares currently outstending. This is 144.02% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 22.96% higher than that of the company.
AusCann Group Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AusCann Group's current stock value. Our valuation model uses many indicators to compare AusCann Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AusCann Group competition to find correlations between indicators driving AusCann Group's intrinsic value. More Info.AusCann Group Holdings is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AusCann Group's earnings, one of the primary drivers of an investment's value.AusCann Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AusCann Group's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AusCann Group could also be used in its relative valuation, which is a method of valuing AusCann Group by comparing valuation metrics of similar companies.AusCann Group is currently under evaluation in shares outstanding category among its peers.
AusCann Fundamentals
| Return On Equity | -0.8 | |||
| Return On Asset | -0.0964 | |||
| Operating Margin | (2.40) % | |||
| Current Valuation | (2.97 M) | |||
| Shares Outstanding | 440.55 M | |||
| Shares Owned By Insiders | 12.71 % | |||
| Shares Owned By Institutions | 16.42 % | |||
| Price To Earning | (53.62) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 7.99 X | |||
| Revenue | 29.73 K | |||
| Gross Profit | 336.67 K | |||
| EBITDA | (5.07 M) | |||
| Net Income | (26.36 M) | |||
| Cash And Equivalents | 5.76 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 39.87 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 23.92 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.83 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.96 | |||
| Market Capitalization | 11.83 M | |||
| Total Asset | 18.45 M | |||
| Net Asset | 18.45 M |
About AusCann Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AusCann Group Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AusCann Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AusCann Group Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. Auscann Group operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in AusCann Pink Sheet
If you are still planning to invest in AusCann Group Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AusCann Group's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |